Renalytix (Reg S) (RENX)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

8.40p
   
  • Change Today:
      0.15p
  • 52 Week High: 12.50p
  • 52 Week Low: 5.62p
  • Currency: UK Pounds
  • Shares Issued: 437.02m
  • Volume: 973,312
  • Market Cap: £36.71m
  • RiskGrade: 348

Regulatory News

Holding(s) in Company 24-Oct-2025 10:12 RNS
Holding(s) in Company 23-Oct-2025 09:09 RNS
Holding(s) in Company 21-Oct-2025 10:08 RNS
Holding(s) in Company 17-Oct-2025 10:26 RNS
Holding(s) in Company 17-Oct-2025 07:00 RNS
Holding(s) in Company 16-Oct-2025 14:31 RNS
Holding(s) in Company 16-Oct-2025 12:15 RNS
Holding(s) in Company 15-Oct-2025 09:48 RNS
Holding(s) in Company 10-Oct-2025 14:34 RNS
Holding(s) in Company 10-Oct-2025 09:56 RNS
Holding(s) in Company 10-Oct-2025 07:01 RNS
$4m balance sheet improvement with bond conversion 10-Oct-2025 07:00 RNS
Holding(s) in Company 09-Oct-2025 16:43 RNS
Holding(s) in Company 07-Oct-2025 15:03 RNS
Holding(s) in Company 03-Oct-2025 14:32 RNS
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

RENX Market Data

Currency UK Pounds
Share Price 8.40p
Change Today 0.15p
% Change 1.82 %
52 Week High 12.50p
52 Week Low 5.62p
Volume 973,312
Shares Issued 437.02m
Market Cap £36.71m
RiskGrade 348

RENX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value Not Available
Price Trend Not Available
Income Not Available
Growth Not Available

RENX Dividends

No dividends found

Trades for 24-Oct-2025

Time Volume / Share Price
16:23 21,568 @ 8.37p
15:31 7,002 @ 8.44p
15:30 5,831 @ 8.42p
15:25 7,000 @ 8.37p
15:23 5,518 @ 8.42p

RENX Key Personnel

CEO James Renwick McCullough

Top of Page